Bellevue Asset Management (Switzerland)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q4	$2.26M	Sell	24,000 -8,000	-25%	-$753K	0.34%	82
2015 Q3	$2.57M	Sell	32,000 -22,000	-41%	-$1.77M	0.42%	75
2015 Q2	$6.47M	Sell	54,000 -10,000	-16%	-$1.2M	0.9%	40
2015 Q1	$6.68M	Buy	+64,000	New	+$6.68M	0.93%	40